RAC1 (P63000) variants and mutations

RAC1 (also known as P63000) is a human protein-coding gene encoding a ras-related C3 botulinum toxin substrate 1 protein. It acts as a molecular switch controlling actin remodeling, cell migration, membrane trafficking, reactive-oxygen production, and developmental signaling. De novo activating or loss-of-function variants can cause neurodevelopmental syndromes with abnormal brain growth and craniofacial features. This analysis covers 508 RAC1 variants and mutations. Of these, 63% have computational variant effect predictions. Disease context includes intellectual disability, autosomal dominant 48, melanoma, and cutaneous melanoma. Example RAC1 variants include Q2*, Q2E, and Q2K.

Variant analysis overview

Variant and mutation evidence

Clinical, disease, and population context

Protein structure and variant hotspots

Data sources

Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.

Notable RAC1 variants

Examples include Q2*, Q2E, Q2K, Q2L, Q2R, Q2P, Q2H, Q2Q. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.